Labcorp Holdings Inc. (LH) Profit Margins
Over the twelve months to 2026-06-30, Labcorp Holdings Inc. (LH) had gross margin 28.9%, operating margin 10.4%, net margin 7.0%, free cash flow margin 8.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LHLabcorp Holdings Inc.Follow LH — free
—
Price chart with a free account
- Market cap
- 26.7B
- P/E TTM
- 27.2
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 42.0% | 41.9% | 41.0% | 39.7% | 38.3% | 36.6% | 33.4% | 29.9% | 30.0% | 28.0% | 28.1% | 35.4% | 38.0% | 31.3% | 27.7% | 27.9% | 28.8% | 28.9% | |
| Operating margin | 19.9% | 19.6% | 17.1% | 18.0% | 17.1% | 15.1% | 11.5% | 13.3% | 12.7% | 11.7% | 11.5% | 17.5% | 23.2% | 12.1% | 6.0% | 8.4% | 9.9% | 10.4% | |
| Net margin | 11.6% | 11.2% | 9.4% | 10.3% | 9.9% | 8.5% | 5.0% | 7.5% | 11.9% | 7.8% | 7.1% | 11.1% | 18.1% | 10.8% | 3.4% | 5.7% | 6.3% | 7.0% | |
| FCF margin | 15.9% | 15.1% | 12.8% | 11.8% | 10.6% | 8.9% | 8.4% | 9.6% | 11.5% | 8.2% | 9.0% | 12.5% | 20.5% | 12.9% | 7.2% | 8.4% | 8.6% | 8.1% |
USD billions · SEC XBRL
Labcorp Holdings Inc. — questions
- What is Labcorp Holdings Inc.'s gross margin?
- 28.9% over the twelve months to 2026-06-30.
- What is Labcorp Holdings Inc.'s operating margin?
- 10.4% over the twelve months to 2026-06-30.
- What is Labcorp Holdings Inc.'s net profit margin?
- 7.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Labcorp Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.